
Sign up to save your podcasts
Or


Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
By Research To PracticeDr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.

67 Listeners

32 Listeners

75 Listeners

15 Listeners

17 Listeners

4 Listeners

2 Listeners

13 Listeners

1 Listeners

118 Listeners